憩室炎の世界市場レポート 2025年

憩室炎市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.4％で29億2,000万米ドルに成長します。予測期間の成長は、大腸内視鏡検査と内視鏡検査、認知度の向上、低侵襲処置、個別化医療に起因します。予測期間の主な動向には、予防対策、診断ツールの強化、共同ケアモデル、ヘルスケア政策の変化などがあります。

喫煙中毒の増加は、今後数年間の憩室炎市場の成長を促進すると予測されます。このような喫煙中毒の増加は、積極的なマーケティング、社会的受容、ストレス、ニコチンの中毒性などの要因によって煽られています。特に若者の間では、社会的影響や同調圧力とともに、電子タバコやVAPEデバイスの入手が可能であることが、喫煙率の上昇をさらに助長しています。喫煙は大腸への血流を損ない、重篤な合併症を引き起こす可能性があるため、憩室疾患の開発リスクの上昇につながり、診断・治療オプションの需要を高めています。例えば、2022年7月、カナダの政府機関であるカナダ統計局は、2021年6月と比較してタバコの生産量が5.8％増加し、タバコの総販売量が2022年5月から1.3％増加して2022年6月には14億本に達したと報告しました。その結果、喫煙中毒の有病率の増加が憩室炎市場の成長を牽引しています。

糖尿病の有病率の上昇も、憩室炎市場の成長を促進すると予想されています。この動向は主に、加工食品の多い食事、座りがちなライフスタイル、肥満率の増加、遺伝的素因、高齢化などの要因によってもたらされています。糖尿病は血管の弱化などの合併症のリスクを高め、大腸を感染症や炎症に対してより脆弱にするため、治療や療法に対するより大きな需要を生み出します。例えば2024年6月、英国の公的医療制度であるNHSイングランドは、糖尿病予備軍と認定された人の数が2023年には361万5330人に上り、2022年の306万5825人から18％増加したと報告しました。40歳未満では、2022年の173,166人から2023年には216,440人と25％近く急増しました。したがって、糖尿病の有病率の増加が憩室炎市場の拡大に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界憩室炎PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の憩室炎市場：成長率分析
• 世界の憩室炎市場の実績：規模と成長, 2019-2024
• 世界の憩室炎市場の予測：規模と成長, 2024-2029, 2034F
• 世界憩室炎総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の憩室炎市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 単純
• 複雑
• 世界の憩室炎市場診断による、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンピュータ断層撮影（CT）スキャン
• 超音波
• 尿検査
• 血液検査
• 世界の憩室炎市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 手術
• 支持療法
• ペニシリン系抗生物質
• 抗生物質
• 栄養補助食品
• 静脈内（IV）輸液
• 世界の憩室炎市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 専門センター
• 病院
• 研究センター
• 世界の憩室炎市場、単純型のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外来治療
• 食事管理
• 抗生物質療法
• 世界の憩室炎市場、複雑なサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 入院
• 外科的介入
• 静脈内抗生物質
• 膿瘍ドレナージ

第7章 地域別・国別分析

• 世界の憩室炎市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の憩室炎市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 憩室炎市場：競合情勢
• 憩室炎市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Novartis AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Abbott Laboratories
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Amgen Inc.
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Astellas Pharma
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 憩室炎市場2029：新たな機会を提供する国
• 憩室炎市場2029：新たな機会を提供するセグメント
• 憩室炎市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Diverticulitis disease is a medical condition marked by inflammation or infection of small pouches that develop in the walls of the colon or large intestine. Symptoms may encompass lower abdominal pain, constipation, diarrhea, and rectal bleeding.

The disease is categorized into two main types sush as uncomplicated and complicated. Uncomplicated diverticulitis refers to the inflammation or infection of these small pouches, known as diverticula, within the colon walls. Various diagnostic methods such as computed tomography (CT) scans, ultrasounds, urine tests, and blood tests are employed. Treatment options encompass medications, surgery, supportive care, penicillin antibiotics, other antibiotics, dietary supplements, and intravenous (IV) fluids. These treatments are utilized by diverse end-users, including specialty centers, hospitals, and research centers.

The diverticulitis disease market research report is one of a series of new reports from The Business Research Company that provides diverticulitis disease market statistics, including diverticulitis disease industry global market size, regional shares, competitors with a diverticulitis disease market share, detailed diverticulitis disease market segments, market trends and opportunities and any further data you may need to thrive in the diverticulitis disease industry. This diverticulitis disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diverticulitis disease market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.04 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to aging population, dietary habits, obesity, advancements in medical imaging.

The diverticulitis disease market size is expected to see strong growth in the next few years. It will grow to $2.92 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to colonoscopy and endoscopy, increased awareness, minimally invasive procedures, personalized medicine. Major trends in the forecast period include preventive measures, enhanced diagnostic tools, collaborative care models, healthcare policy changes.

The increasing prevalence of smoking addiction is anticipated to drive the growth of the diverticulitis disease market in the coming years. This rise in smoking addiction is fueled by factors such as aggressive marketing, social acceptance, stress, and the addictive nature of nicotine. The availability of e-cigarettes and vape devices, along with social influences and peer pressure, particularly among youth, further contributes to the rising smoking rates. Smoking is linked to an increased risk of developing diverticular disease as it impairs blood flow to the colon and can lead to severe complications, thereby elevating the demand for diagnostic and therapeutic options. For example, in July 2022, Statistics Canada, a Canadian government agency, reported a 5.8% increase in cigarette production compared to June 2021, with total cigarette sales rising by 1.3% from May 2022 to reach 1.4 billion in June 2022. Consequently, the increasing prevalence of smoking addiction is driving the growth of the diverticulitis disease market.

The rising prevalence of diabetes is also expected to propel the growth of the diverticulitis disease market. This trend is mainly driven by factors such as diets high in processed foods, sedentary lifestyles, increasing obesity rates, genetic predispositions, and an aging population. Diabetes increases the risk of complications like weakened blood vessels, making the colon more vulnerable to infections and inflammation, thus creating greater demand for treatments and therapies. For instance, in June 2024, NHS England, the UK's publicly funded healthcare system, reported that the number of individuals identified with pre-diabetes rose to 3,615,330 in 2023, marking an 18% increase from 3,065,825 in 2022. Among those under 40, cases surged nearly 25%, from 173,166 in 2022 to 216,440 in 2023. Therefore, the growing prevalence of diabetes is contributing to the expansion of the diverticulitis disease market.

Increasing healthcare expenditures are also expected to drive the growth of the diverticulitis disease market. Health expenditures encompass all costs associated with providing health services, family planning activities, nutrition programs, and emergency health assistance. A rise in healthcare spending significantly supports the development of more effective therapies and medical technologies for treating diverticulitis disease. For instance, in May 2023, the UK's Office for National Statistics reported that healthcare spending in the UK reached approximately $362.08 billion (£292 billion), reflecting a 5.6% nominal increase. Additionally, long-term health and social care expenditure grew by 2.8% in real terms in 2022. As a result, the increase in healthcare expenditure is fostering growth in the diverticulitis disease market.

Major companies operating in the diverticulitis disease market are developing innovative drugs and getting them approved to sustain their position in the market. Drug development can lead to the development of more effective treatments for diverticulitis, reducing the risk of complications and improving patient outcomes. For instance, in April 2023, the United States Food and Drug Administration, a US-based federal organization, approved Seres' microbiota drug for recurrent gut infections. This drug is designed to treat recurring gut infections and prevent the recurrence of Clostridioides difficile (C. diff.) infections in adults aged 18 and over. The approval of Vowst was based on a clinical trial that enrolled 346 patients with recurrent CDI. The trial found that patients who received Vowst were significantly less likely to experience a recurrence of the infection than those who received a placebo. The drug is taken orally and is based on microbiota containing Firmicutes spores, which are known to contribute to a healthy microbiome that can resist C. diff. colonization.

Major companies operating in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

North America was the largest region in the diverticulitis disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diverticulitis disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diverticulitis disease market consists of revenues earned by entities by providing diagnostic services, pain management, nutritional therapy and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diverticulitis disease market also includes sales of antibiotics, dietary supplements, high-fiber foods and pain medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diverticulitis Disease Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diverticulitis disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diverticulitis disease ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diverticulitis disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Uncomplicated; Complicated
• 2) By Diagnosis: Computed Tomography (CT) Scan; Ultrasound; Urine Test; Blood Test
• 3) By Treatment: Medications; Surgery; Supportive care; Penicillin Antibiotic; Antibiotics; Dietary Supplements; Intravenous (IV) Fluids
• 4) By End-User: Specialty Centers; Hospitals; Research centers
• Subsegments:
• 1) By Uncomplicated: Outpatient Treatment; Dietary Management; Antibiotic Therapy
• 2) By Complicated: Hospitalization; Surgical Intervention; Intravenous Antibiotics; Abscess Drainage
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diverticulitis Disease Market Characteristics

3. Diverticulitis Disease Market Trends And Strategies

4. Diverticulitis Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Diverticulitis Disease Growth Analysis And Strategic Analysis Framework

• 5.1. Global Diverticulitis Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Diverticulitis Disease Market Growth Rate Analysis
• 5.4. Global Diverticulitis Disease Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Diverticulitis Disease Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Diverticulitis Disease Total Addressable Market (TAM)

6. Diverticulitis Disease Market Segmentation

• 6.1. Global Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Uncomplicated
• Complicated
• 6.2. Global Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Computed Tomography (CT) Scan
• Ultrasound
• Urine Test
• Blood Test
• 6.3. Global Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medications
• Surgery
• Supportive care
• Penicillin Antibiotic
• Antibiotics
• Dietary Supplements
• Intravenous (IV) Fluids
• 6.4. Global Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Specialty Centers
• Hospitals
• Research centers
• 6.5. Global Diverticulitis Disease Market, Sub-Segmentation Of Uncomplicated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Outpatient Treatment
• Dietary Management
• Antibiotic Therapy
• 6.6. Global Diverticulitis Disease Market, Sub-Segmentation Of Complicated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitalization
• Surgical Intervention
• Intravenous Antibiotics
• Abscess Drainage

7. Diverticulitis Disease Market Regional And Country Analysis

• 7.1. Global Diverticulitis Disease Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Diverticulitis Disease Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diverticulitis Disease Market

• 8.1. Asia-Pacific Diverticulitis Disease Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diverticulitis Disease Market

• 9.1. China Diverticulitis Disease Market Overview
• 9.2. China Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diverticulitis Disease Market

• 10.1. India Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diverticulitis Disease Market

• 11.1. Japan Diverticulitis Disease Market Overview
• 11.2. Japan Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diverticulitis Disease Market

• 12.1. Australia Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diverticulitis Disease Market

• 13.1. Indonesia Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diverticulitis Disease Market

• 14.1. South Korea Diverticulitis Disease Market Overview
• 14.2. South Korea Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diverticulitis Disease Market

• 15.1. Western Europe Diverticulitis Disease Market Overview
• 15.2. Western Europe Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diverticulitis Disease Market

• 16.1. UK Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diverticulitis Disease Market

• 17.1. Germany Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diverticulitis Disease Market

• 18.1. France Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diverticulitis Disease Market

• 19.1. Italy Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diverticulitis Disease Market

• 20.1. Spain Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diverticulitis Disease Market

• 21.1. Eastern Europe Diverticulitis Disease Market Overview
• 21.2. Eastern Europe Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diverticulitis Disease Market

• 22.1. Russia Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diverticulitis Disease Market

• 23.1. North America Diverticulitis Disease Market Overview
• 23.2. North America Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diverticulitis Disease Market

• 24.1. USA Diverticulitis Disease Market Overview
• 24.2. USA Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diverticulitis Disease Market

• 25.1. Canada Diverticulitis Disease Market Overview
• 25.2. Canada Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diverticulitis Disease Market

• 26.1. South America Diverticulitis Disease Market Overview
• 26.2. South America Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diverticulitis Disease Market

• 27.1. Brazil Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diverticulitis Disease Market

• 28.1. Middle East Diverticulitis Disease Market Overview
• 28.2. Middle East Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diverticulitis Disease Market

• 29.1. Africa Diverticulitis Disease Market Overview
• 29.2. Africa Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diverticulitis Disease Market Competitive Landscape And Company Profiles

• 30.1. Diverticulitis Disease Market Competitive Landscape
• 30.2. Diverticulitis Disease Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Diverticulitis Disease Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Novartis AG
• 31.3. Sanofi S.A.
• 31.4. Bristol-Myers Squibb Company
• 31.5. AstraZeneca plc
• 31.6. Abbott Laboratories
• 31.7. GlaxoSmithKline plc
• 31.8. Takeda Pharmaceutical Company Limited
• 31.9. Eli Lilly and Company
• 31.10. Amgen Inc.
• 31.11. Viatris Inc.
• 31.12. Teva Pharmaceutical Industries Ltd.
• 31.13. Astellas Pharma
• 31.14. Eisai Co. Ltd.
• 31.15. Sun Pharmaceutical Industries Ltd.

32. Global Diverticulitis Disease Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diverticulitis Disease Market

34. Recent Developments In The Diverticulitis Disease Market

35. Diverticulitis Disease Market High Potential Countries, Segments and Strategies

• 35.1 Diverticulitis Disease Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Diverticulitis Disease Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Diverticulitis Disease Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer